Let's discuss how Pullan Consulting can support and advance your strategic plans for growth.

Oversight, guidance and support for a range of MS research initiatives, fundraising activities, partnerships and public outreach

Not-for-profit organization providing education, research funding & support services for people living with hydrocephalus & spina bifida

Aqiok Studios possesses a core expertise in e-Commerce across a continuous spectrum of digital advertising, influencers, marketplaces and fulfilment in key global markets. Aqiok Studios is an operationally efficient partner for high growth companies that want actionable, profitable results at scale internationally. Aqiok Studios excels at ‘moving units‘ for a range of clientele primarily in the areas of consumer package goods, retail and financial services.

Energized by the pursuit of profitable corporate growth, I am responsible for advancing global licensing, acquisition and divestment strategies and evaluating co-development investment opportunities, typically ranging from USD $100M - $1B NPV. Board directors and executive management gain confidence in my resource investment and commercial launch strategy recommendations, which are predicated on 360-degree type analyses, valuation models and achievable milestones. Passionately dedicated to championing novel business solutions and strategic initiatives that create tangible corporate value, I lead life cycle management and P&L activities for our key brands. Infrastructure expansion plans and resource allocation is an integral focus, with purview for functions including marketing, business development, market research, forecasting, market access, reimbursement and setting new therapy pricing strategy.

Tracking industry-leading launch campaigns for applicable insights, I am responsible for leading global launch and commercialization plans for specialty therapeutics and rare disease assets. Generating value-focused reimbursement strategy, pricing and forecasting models that reliably guide and support long-term distribution plans. With a mantra to deliver value for all stakeholders, I guide payer market access campaigns that earn timely formulary listings. Evaluating rebate impact, potential risk-sharing agreements and channel focus refinement has enabled operational strategies that improve margins and profitability. Leadership of functions encompassing business development, market access, pricing, marketing, forecasting, research & analytics.

With a passion for discerning direction of future treatment paradigms, I analyze target markets and competitive landscapes for well-informed product positioning and value proposition development. Driving early brand messaging development and disease education programs while collaborating with medical affairs for publication plans. Generating launch plans for North American markets, and evaluating regulatory, commercial and financial factors influencing the feasibility and applicability of such critical pillars to enable launch success in EU and emerging markets. Reporting to the CEO, developed infrastructure and commercialization plans, aligning multi-disciplinary resource needs for launch readiness.

Reverse take over of LKP by Osoyoos Cannabis Inc.; CSE listing with ticker: OSO. Focused on the extraction of oils and cannabinoids for the medical and recreational cannabis markets.

Health and wellness OTC products promoted through e-commerce and retail channels. Listed on the TSX Venture Exchange: RLV

Developed and coordinated global and national strategic launch and marketing plans for new and established products in Cystic Fibrosis and Gastroenterology. Provided market and opportunity assessments based on key insights from primary and secondary research; contributed actionable therapeutic area strategies for synergistic and key indications of interest. Commercial leadership role representing Canadian stakeholder views at global / international sales and marketing meetings.